Skip to main content

Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers Pricing

Legal

Privacy Policy Terms of Service About Our Crawler Content Removal Your Privacy Choices

© 2026 Formulate. Pharma Jobs with Drug Intelligence.

Neurology Jobs in Biotech & Pharma | Formulate

Neurology Jobs

8,969 open positions in neurology

Oncology Immunology Rare Diseases Infectious Diseases Cardiovascular Metabolic Diseases Gene Therapy Cell Therapy

Marketing and Education Executive

Johnson & Johnson

Posted 1y ago

Shanghai, China (Field-based)

Full-time

CommercialNeurology

Executive

H-1B · 1 FY23

Category Manager Direct Precision Materials

Johnson & Johnson

Posted 1y ago

Danvers, Massachusetts, United States of America (Hybrid Work)

$128K - $171K

Full-time

NeurologyMANAGER

H-1B · 1 FY23

FSP CRA(Guangzhou and Southern cities)

Fortrea

Posted 1y ago

Guangzhou (Hybrid)

Full-time

Clinical OperationsNeurologyMID

Product and Customer Value Manager - Neuroscience

Johnson & Johnson

Posted 1y ago

Warsaw, Masovian, Poland (Hybrid Work)

Full-time

NeurologyMANAGER

H-1B · 1 FY23

Rechtsreferendar (m/w/d)

Roche

Posted 1y ago

Grenzach

Full-time

NeurologyMID

H-1B · 1 FY23

Join Our MedTech Talent Pool - Engineers, Scientists, Clinical, and R&D Experts

VahatiCor

Posted 1y ago

Santa Clara, California

Human ResourcesNeurologyMID

Site Monitor II - FSP

Parexel

Posted 1y ago

Remote

RemoteClinical OperationsNeurologyMID

H-1B · 1 FY23

Head, Communications and Public Affairs, India

Johnson & Johnson

Posted 1y ago

IN014 Mumbai Mahim; IN018 Gurgaon (Hybrid Work)

Full-time

Government AffairsNeurologyMID

H-1B · 1 FY23

Alternance - Market Access (H/F)

AstraZeneca

Posted 1y ago

France - Levallois Perret

Full-time

Related drug: COTAZYM Related drug: Cutaquig

Condition in scope: Paroxysmal Nocturnal Hemoglobinuria Condition in scope: Atypical Hemolytic Uremic Syndrome

CommercialNeurologyMID

H-1B · 4 FY23

Previous
1
448
449